Renfu Pharmaceutical's Class 1 New Drug Propofol Disodium Phosphate for Injection Approved
With the coming Oil & Gas Asia Exhibition in Pakistan, ECHEMI rolls out a new bulk purchasing activity for its new and old customers. This activity will be valid before March 16 when the exhibition come to the end. The more you buy, the more money you will save.
How to join this bulk purchasing?
You can enjoy the most favorable prices via three steps:
First, you should come to the home page of ECHEMI, then you can see the the following page:
Second, input your demand and submit the inquiry.
Third, ECHEMI will give you a reply within 1 working day after receiving your inquiry.
Opportunity knocks but once! Come on, seize this opportunity right now!
Looking for chemical products? Let suppliers reach out to you!
You May Interested In
β-Nicotinamide Adenine Dinucleotide High Quality NAD+ CAS 53-84-9 Exclusive Production Factory CAS NO.53-84-9
$75/UNIT FOB
GHKCU 50mg High Purity Peptide Not For Human Use
$78/UNIT FOB
2026-07-16
-
Life Sciences Industry Overview
The coverage spans the global life sciences industry across pharmaceuticals and food & nutrition, tracking the shift from lowest-cost sourcing to supply continuity, quality, and risk management, along with product trends and the growing edge of differentiated, globally capable players.Published in: June.2026
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
25 million with one injection?! The record for 'the world's most expensive drug' is still controversial...
-
Tonghua Dongbao's 'Liraglutide Injection' Declared for Listing
-
Pfizer GDF15 Monoclonal Antibody Ponsegromab Injection Applied for Clinical Application
-
Approval of The Clinical Trial Application of WuXi Giant Norricy Orenza Injection For r/r B-ALL
-
A panoramic analysis of traditional Chinese medicine injection
-
Adjusting the price of rituximab injection produced by Shanghai Fuhong Hanlin
-
Taiji Group stirred up 1.5 bn injections and Pfizer and Hawson met their rivals.
-
Glenmark’s $1 Billion Cancer Bet: Oncology Revolution Set to Ignite in FY28
-
EFSA Confirms Safety of Vitamin E TPGS as Food Additive New Opinion Covers Multiple Use Levels
-
Indian Pharma Urges US to Exempt Generics as 50 Percent Tariffs Loom National Security Probe Sparks Supply Fears
Recommend Reading
-
Novo Nordisk Reports Theft of Six Drug Batches in India Authorities Warn of Severe Patient Safety Risks
-
EFSA Reaffirms Safety of E948 Oxygen and E949 Hydrogen in All Foods No Health Risks Detected
-
Glenmark Recalls Over 110000 Bottles of BP and COPD Drugs in US Due to Safety Concerns
-
Parliamentary Panel Urges Expanded Price Controls as Dozens of Cancer Drugs Remain Unregulated
-
Glenmark Targets 10–15 Percent CAGR in India by Shifting to High-Margin Drugs AbbVie Deal and New Launches Boost Outlook
-
Lipoid Kosmetik Announces New U.S. Market Distribution Partnership with Omya
-
Crude oil prices fall, domestic refined oil retail prices are about to be reduced
-
China Activates Blocking Rules in Response to U.S. Sanctions on Petrochemical Firms
-
Coking Coal Market Prices Remain Stable
-
Insufficient Positive Factors, Polyethylene Struggles to Rise